These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3079088)

  • 1. Cellular characteristics of liver allograft rejection.
    Lautenschlager I; Höckerstedt K; Ahonen J; Eklund B; Korsbäck C; Pettersson E; Salmela K; Scheinin TM; von Willebrand E; Häyry P
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2485-6. PubMed ID: 3079088
    [No Abstract]   [Full Text] [Related]  

  • 2. Induction of ICAM-1 on hepatocyte membranes during liver allograft rejection and infection.
    Steinhoff G; Behrend M; Pichlmayr R
    Transplant Proc; 1990 Oct; 22(5):2308-9. PubMed ID: 2219382
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunohistologic labeling of infiltrating T lymphocytes in hepatic allografts: a rejection indicator.
    Perkins JD; Wiesner RH; Banks PM; LaRusso NF; Krom RA
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2474-5. PubMed ID: 2856283
    [No Abstract]   [Full Text] [Related]  

  • 4. Recruitment of lymphocytes to human liver allografts during rejection.
    Hathaway M; Adams DH; Burnett D; Elias E
    Transplant Proc; 1990 Oct; 22(5):2306-7. PubMed ID: 2219381
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunoglobulins in liver allograft rejection: evidence for deposition and secretion within the liver.
    Adams DH; Hubscher SG; Burnett D; Elias E
    Transplant Proc; 1990 Aug; 22(4):1834-5. PubMed ID: 2202131
    [No Abstract]   [Full Text] [Related]  

  • 6. Induction of ICAM-1 on hepatocytes precedes the lymphoid activation of acute liver allograft rejection and cytomegalovirus infection.
    Lautenschlager I; Höckerstedt K
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1429-30. PubMed ID: 8095108
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficiency of FK 506 and CyA to prevent acute cellular rejection of pig liver allografts.
    Lautenschlager I; Höckerstedt K; Mäkisalo H; Orko R; Taskinen E
    Transplant Proc; 1991 Aug; 23(4):2233-5. PubMed ID: 1714650
    [No Abstract]   [Full Text] [Related]  

  • 8. The pattern of rejection and susceptibility to different kinds of immunosuppression after combined liver, duodenum, and pancreas transplantation in swine--immunosuppressive drugs versus ex vivo immunomodulation of the allograft.
    Saito S; Fujiwara T; Sakagami K; Kobayashi N; Takaishi Y; Orita K
    Transplant Proc; 1995 Feb; 27(1):518-9. PubMed ID: 7533420
    [No Abstract]   [Full Text] [Related]  

  • 9. Relationship between cellular and molecular markers of inflammation in human kidney allograft rejection.
    von Willebrand E; Häyry P
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1644-5. PubMed ID: 3079030
    [No Abstract]   [Full Text] [Related]  

  • 10. A randomized clinical trial comparing OKT3 and steroids for treatment of hepatic allograft rejection.
    Cosimi AB; Cho SI; Delmonico FL; Kaplan MM; Rohrer RJ; Jenkins RL
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2431-3. PubMed ID: 3079083
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnosis and grading of liver allograft rejection: a European perspective.
    Hübscher S
    Transplant Proc; 1996 Feb; 28(1):504-7. PubMed ID: 8644330
    [No Abstract]   [Full Text] [Related]  

  • 12. Lack of evidence for an effect of donor irradiation on liver allograft rejection.
    Yokoi Y; Nakamura S; Suzuki S; Baba S; Naji A; Amemiya H; Kimura H
    Transplant Proc; 1996 Jun; 28(3):1725-6. PubMed ID: 8658857
    [No Abstract]   [Full Text] [Related]  

  • 13. Different cellular patterns associated with hepatitis C virus reactivation, cytomegalovirus infection, and acute rejection in liver transplant patients monitored with transplant aspiration cytology.
    Lautenschlager I; Nashan B; Schlitt HJ; Hoshino K; Ringe B; Tillmann HL; Manns M; Wonigeit K; Pichlmayr R
    Transplantation; 1994 Dec; 58(12):1339-45. PubMed ID: 7809926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histologic response to OKT3 therapy for hepatic allograft rejection.
    Rohrer RJ; Jenkins RL; Khettry U; Benotti PN; Dodson TF; Karlson CG; Georgi BA; Monaco AP
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2459-61. PubMed ID: 3079086
    [No Abstract]   [Full Text] [Related]  

  • 15. Renal target structures in acute allograft rejection.
    Leszczynski D; Laszczynska M; Halttunen J
    Transplant Proc; 1987 Feb; 19(1 Pt 1):378. PubMed ID: 3079159
    [No Abstract]   [Full Text] [Related]  

  • 16. Ex vivo perfusion of livers with anti-class II antibody and acute rejection in canine liver transplantation.
    Sakagami K; Saito S; Kurozumi Y; Kobayashi N; Fujiwara T; Matsuno T; Orita K
    Transplant Proc; 1993 Apr; 25(2):1959-61. PubMed ID: 8470243
    [No Abstract]   [Full Text] [Related]  

  • 17. Laboratory monitoring of nonrenal allograft rejection.
    Lautenschlager I; Häyry P
    Clin Lab Med; 1991 Sep; 11(3):653-70. PubMed ID: 1934969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of monoclonal antibodies to study in vivo and in vitro-activated lymphocytes.
    Aversa GG; Waugh JA; Bishop GA; Hall BM
    Transplant Proc; 1989 Feb; 21(1 Pt 1):349-50. PubMed ID: 2650146
    [No Abstract]   [Full Text] [Related]  

  • 19. Low level of interleukin 10 synthesis during liver allograft rejection.
    Conti F; Boulland ML; Leroy-Viard K; Chereau C; Dousset B; Soubrane O; Weill B; Calmus Y
    Lab Invest; 1998 Oct; 78(10):1281-9. PubMed ID: 9800954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of blood group antigens including HLA markers on human liver allografts.
    Gugenheim J; Rouger P; Gane P; Capron-Laudereau M; Reynes M; Bismuth H
    Transplant Proc; 1987 Feb; 19(1 Pt 1):223-5. PubMed ID: 3079153
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.